Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session



  • Sintx Technologies, Inc. SINT shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical machining.
  • Venus Concept Inc. VERO gained 63.3% to $0.4122 after the company announced it received a 510(k) clearance from the FDAto market its AI.ME next generation robotic technology for fractional skin resurfacing.
  • Laser Photonics Corporation LASE jumped 40% to $2.1499 after the company announced it received an order from the largest glass manufacturer in North America.
  • Cenntro Electric Group Limited CENN rose 33.6% to $0.3561. Cenntro started shipments of LS260 and LS100 vans to European Markets.
  • F-star Therapeutics, Inc. FSTX gained 29.9% to $5.59.
  • Rekor Systems, Inc. REKR jumped 28% to $0.7622. Rekor announced financing to solidify cash position and accelerate business growth and technology development.
  • Mobile Global Esports Inc. MGAM jumped 25% to $0.7885. Maxim Group initiated coverage on Mobile Global Esports with a Buy rating and announced a price target of $1.5.
  • Kineta, Inc. KA surged 25% to $4.70.
  • Blue Star Foods Corp. BSFC gained 23.7% to $0.5319.
  • Appreciate Holdings, Inc. SFR rose 22.6% to $1.68.
  • BeyondSpring Inc. BYSI gained 22.5% to $2.07.
  • Erayak Power Solution Group Inc. RAYA gained 22.1% to $3.2955 after jumping over 47% on Tuesday.
  • Ecoark Holdings, Inc. ZEST rose 21.4% to $0.34.
  • Grove Collaborative Holdings, Inc. GROV rose 21% to $0.2476. Grove announced receipt of continued listing standards notice from NYSE.
  • Akari Therapeutics, Plc AKTX gained 20.6% to $0.5347.
  • CalAmp Corp. CAMP gained 20.1% to $4.12 after the company reported better-than-expected Q3 sales results.
  • DatChat, Inc. DATS surged 19.4% to $0.4211.
  • Zymeworks Inc. ZYME rose 18.6% to $8.40. Jazz Pharmaceuticals and Zymeworks announced that Jazz has exercised option to continue exclusive development and commercialization rights to Zanidatamab.
  • Evelo Biosciences, Inc. EVLO jumped 18.5% to $1.73.
  • Pagaya Technologies Ltd. PGY gained 18.4% to $0.7862.
  • Altimmune, Inc. ALT gained 18.2% to $14.07. Altimmune announced topline results from its 24-week (12-week extension) trial of pemvidutide in subjects with Non-Alcoholic Fatty Liver Disease (NAFLD).
  • Forian Inc. FORA climbed 18.1% to $2.5750. New York has selected Forian's Biotrack as the State's Cannabis Seed to sale track and trace system.
  • Adaptive Biotechnologies Corporation ADPT gained 17.7% to $8.35 after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $7.5 to $14.
  • Mereo BioPharma Group plc MREO surged 16.2% to $0.6160.
  • Avaya Holdings Corp. AVYA gained 14.6% to $0.2386.
  • NIKE, Inc. NKE rose 13.9% to $117.51 after the company reported better-than-expected results for its second quarter on Tuesday.
  • TransCode Therapeutics, Inc. RNAZ rose 13.2% to $0.3751 after dropping 27% on Tuesday.
  • Nine Energy Service, Inc. NINE gained 12.7% to $11.89.
  • Six Flags Entertainment Corporation SIX surged 12.3% to $23.50 after Land & Buildings issued a presentation highlighting an opportunity to unlock substantial real estate value at Six Flags. Land & Buildings is approximately a 3% shareholder of Six Flags.
  • Butterfly Network, Inc. BFLY shares gained 11.1% to $2.4550. Butterfly Network recently completed successful deployment of 500 Butterfly iQ+ devices and training of 500+ healthcare workers across 224 facilities in Kenya.
  • 374Water, Inc. SCWO jumped 10.8% to $2.77.
  • Energy Focus, Inc. EFOI rose 7.6% to $0.3434 after declining 11% on Tuesday. Energy Focus, last month, posted a Q3 loss of $0.29 per share.
  • FedEx Corporation FDX rose 4% to $170.79. FedEx posted upbeat earnings for its second quarter, while sales missed expectations. The company also said it sees FY23 earnings of $13.00 to $14.00 per share, versus analysts’ estimates of $14.08 per share.



  • Pingtan Marine Enterprise Ltd. PME shares fell 100% to $0.0001.
  • Meiwu Technology Company Limited WNW dropped 78% to $0.4099.
  • Core Scientific, Inc. CORZ shares dipped 50.5% to $0.1026 after the company filed for Chapter 11 bankruptcy.
  • IceCure Medical Ltd ICCM fell 39.8% to $1.5650. IceCure reported pricing of 8,787,880 share public offering at $1.65 per share.
  • Celyad Oncology SA CYAD fell 37.4% to $0.6516 after the company reported it has decided to discontinue the development of its remaining clinical program CYAD-211.
  • WeTrade Group, Inc. WETG declined 25.7% to $0.2860.
  • Singularity Future Technology Ltd. SGLY dropped 23.6% to $0.5599.
  • Vivos Therapeutics, Inc. VVOS fell 20.7% to $0.42 after posting a loss for the third quarter.
  • Lipella Pharmaceuticals Inc. LIPO fell 20.6% to $3.7399.
  • UTime Limited UTME fell 20% to $0.9998.
  • Ostin Technology Group Co., Ltd. OST dropped 18.9% to $0.7773.
  • Quotient Limited QTNT fell 17.8% to $0.2334.
  • Athenex, Inc. ATNX fell 17% to $0.1327. Athenex announced Quantum Leap Healthcare Collaborative reported a trial result of I-SPY2 trial for oral paclitaxel in combination with PD-1 and carboplatin in neoadjuvant breast cancer.
  • Magenta Therapeutics, Inc. MGTA dipped 15.9% to $0.33. BTIG maintained Magenta Therapeutics with a Buy and lowered the price target from $6 to $3.
  • Caravelle International Group CACO dropped 15.2% to $1.79 after dropping 57% on Tuesday.
  • Rite Aid Corporation RAD shares fell 13.9% to $11.89 after the company reported results for its third quarter.
  • Lion Group Holding Ltd. LGHL fell 13.5% to $1.2450.
  • Surrozen, Inc. SRZN dropped 13.4% to $0.43.
  • GEE Group, Inc. JOB fell 12.6% to $0.5661 after the company reported worse-than-expected Q4 sales results.
  • Calavo Growers, Inc. CVGW dropped 11.6% to $29.92 after the company reported worse-than-expected Q4 EPS and sales results.
  • BlackBerry Limited BB fell 7.8% to $3.82 after the company reported Q4 earnings results.
  • Lanvin Group Holdings Limited LANV dropped 7.8% to $6.76.
  • Cosmos Health Inc. COSM fell 7.1% to $8.14 after gaining 15% on Tuesday. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market.
  • Terns Pharmaceuticals, Inc. TERN fell 6.6% to $7.89 after the company reported pricing of $75 million public offering.
  • Pebblebrook Hotel Trust PEB fell 5.2% to $13.66 after the company lowered its FY22 FFO per share guidance.

Read This Next: Bitcoin Edges Higher But Remains Below This Key Level; Helium Emerges As Top Gainer

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!